An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
Conditions: Hepatitis B, Chronic; Lipid Disorder Interventions: Drug: oral Tenofovir Amibufenamide 25mg each day; Drug: lipid lowering drugs (e.g. Atorvastatin and amlodipine.) Sponsor: Wuhan Union Hospital, China Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | China Health | Hospitals | Lipitor | Norvasc | Research | Statin Therapy | Study | Viread | Zivast